Relief Therapeutics Holding AG (RLFTF)

[Bob1968]

Thanks for posing that. Interesting that they mentioned NRX as a partner. I hope both companies get their acts together. The legal bickering is not helping either of them.

In part from the application filing:

RLF-100TM is currently late-stage clinical testing in the U.S for acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) associated with the SARS-CoV-2 virus (COVID-19) through Relief's collaboration partner in the U.S., NeuroRx, Inc. VIP has been granted Fast Track Designation by FDA for the treatment of critical COVID-19 patients with respiratory failure.